Refine by
Arterial Hypertension Suppliers & Manufacturers
10 companies found
Premium
based inHorsholm, DENMARK
At TannerMedico A/S, our aim is to help you sleep comfortable, breathe easier and live healthier. We truly believe that any good treatment aims at killing the cause and not just the symptoms. We are a Scandinavian company with the corporate ...
3 bottles of Asonor anti snoring solution, covering 3 month peaceful night’s sleep for you and your partner. Plus a travel kit. Award winning and Clinically proven Asonor anti snoring solution is ranked as one of the world’s best ...
based in, CHINA
Our company focuses on the export and distribution of chemical products. We provide customers with various high-quality chemicals, such as food additives, surfactants, catalysts and additives, essence and fragrances, chemical raw materials, ...
Property: Value/Description. Molecular Formula: C22H30N6O4S . Molecular Weight: 474.58 g/mol . Appearance: White to off-white crystalline powder. Melting Point: 187–189 °C. Boiling Point: 672.4 °C at 760 mmHg. Density: 1.4 ± 0.1 ...
based inStockholm, SWEDEN
Gesynta Pharma is a Swedish pharmaceutical company that develops unique drug candidates with the aim to reduce harmful inflammation and increase blood flow in the body’s microvasculature, thereby providing safe and efficacious treatments for several ...
based inSão Paulo, BRAZIL
We were born on July, 15, 1994 in Amparo/SP, and the essence of our company is to use state-of -the-art technology to develop equipment for human wellness, in physical rehabilitation, esthetics or esthetic medicine. Today, we are located in a built ...
Dermotonus Slim is a portable device designed for mechanical massage techniques (vacuum therapy and endermotherapy) in esthetic treatments. It presents an optional kit for diamond peeling, suction pressure from 0 to – 550mmHg (negative ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
SRT 1720 dihydrochloride is a selective and orally active activator of SIRT1 with an EC50 of 0.10 μM, and shows less potent activities on SIRT2 and ...
based inKiel, GERMANY
tiakis biotech AG (“tiakis”) – formerly Proteo Biotech AG - is the next generation preventive therapeutic technology company. We focus on our clinical-stage proprietary and pioneering tissue protective drug ...
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the ...
based inCaesarea Industrial Park (N), ISRAEL
V-WAVE was established in Israel in 2009 with a focus on developing percutaneous implantable technologies for patients with chronic heart failure. Technology designed by V-Wave, highlighted by its Ventura Interatrial Shunt System, was designed to ...
Heart failure (HF) is a condition where the heart is not pumping enough blood to meet the needs of the body. When heart failure occurs, there is an increase in pressure in the heart and lungs, plus fluid build-up in the lungs. The fluid causes ...
based inKyiv, UKRAINE
Darnitsa is the leader of the Ukrainian market in physical terms. 90 years of experience and GMP production certification have allowed us to earn confidence in 16 countries worldwide. We produce 180 products with a focus on cardiology, neurology, ...
Valsartan is an active specific angiotensin II receptor antagonist for oral use. It selectively influences AT1 subtype receptors responsible for the known effects of angiotensin II. Elevated plasma angiotensin II levels after AT1 receptor blockade ...
based inSilver Spring, MARYLAND (USA)
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation (PBC). Our public benefit purpose is to provide a brighter future for patients through (a) the development of novel pharmaceutical ...
TYVASO (treprostinil) is a prostacyclin mimetic indicated for the treatment of: Pulmonary arterial hypertension (PAH; WHO Group 1) to improve exercise ability. Studies establishing effectiveness predominately ...
based inNizhniy Novgorod, RUSSIA
We develop, manufacture and supply rehabilitation aids and physiotherapy equipment, research and study new methods of recovery. The group of companies includes several scientific and production firms. The Company employs an integrated approach and ...
Magnitoturbotron is a physiotherapy equipment for systemic magnetotherapy. The device has a capsule-like form with a large diameter inductor installed ...